Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. It is a true Indian Multi-National Company with a multi-ethnic workforce of many Wockhardt Associates from many different nationalities globally. It has many research centres and several manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.

Business area of the company

The company is a pharmaceutical and biotechnology company. The company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines.

Businesses of the company

• New drug discovery
• Branded pharmaceuticals
• Contract manufacturing
• Biologicals in diabetes
• Vaccines
• API

Awards

2009

• Outstanding National Citizen Award by National Citizens Guild.
  
• Strathmore’s Who’s Who - Social Entrepreneur of the Year.

2010

• AmeriCares India Spirit of Humanity Award.
  
• USA BF Foundation of the Year Award.
  
• HEF Award for ‘Outstanding contribution to the teaching community with special reference to Human Values.
  
• Best Pharma CSR award at the Pharmaceutical Leadership Summit.

2011

• IDF - CSR Award.

2012

• Inclusive India Award under the Corporate category for ‘Best Social Work in the Realm of Primary Healthcare’.
• IPE CSR Corporate Governance Award.

2013

• Rajiv Gandhi Global Excellence Award.
  
• Rajiv Gandhi Excellence Award.
  
• Bharat Gaurav Award.
  
• Asian CSR Leadership Awards.
  
• CSR Excellence & Leadership Award.
  
• Asia Peace Award.

2015

• Best CSR Project in Healthcare for Mobile 1000 Medical vans - India CSR.
  
• Best Community Development Award for Mobile 1000 - World CSR Congress.
  
• CSR Professional of the Year - World CSR Congress.
  
• Maharashtra Class Owners Association Meritorious Award for valuable contribution in the field of education.
  
• Bronze Award for Table Calendar - A.B.C.I (Association of Business Communicators of India).
  
• Social Entrepreneur of the Year 2015 - Pharma Leaders.
  
• Swachh Bharat Samman - India CSR.
  
• Best Environment Friendly Project for Bio-Toilets - Asian CSR Leadership Awards.

2016

• CSR Leadership Award.
  
• Lions CSR Precious Award.
  
• Champion of WSIS Prize 2016 - World Summit on the Information Society.
  
• Outstanding Leadership Award - Nurturing the Future Foundation.
  
• Peace Leader of the Year 2016 - 7th India Leadership Conclave and Indian Affairs Business Leadership Awards 2016.
  
• Best Service Award for Significant National Contribution - Institute of Technology & Science.
  
• Asia Healthcare Excellence Award - CMO Asia.

2017

• Excellence Award for Corporate Social Responsibility & Peace Mission - Indian Virtual University for Peace and Education (IVUP).
  
• Global NGO Excellence Award for Excellence in Mother & Child Care - World CSR Day.
  
• CSR Humanity Award’ by India CSR.
  
• Lifetime Achievement Award from the National Institute of Cleanliness Education and Research (NICER).
  
• Indian of the Year 2017 (Social Service) by ILC Power Brand.
  
• The Rotary Peace Ambassador Award by Rotary.
  
• CSR Impact Award by IndiaCSR.
  
• Magnificient Man Choice Award with specialization in CEO CSR Excellence from Hopewill International Business Academy.

2018

• Game Changer Award by The HR Club.
  
• Sabarmati Festival Foundation Award for Outstanding Social Work from Sabarmati Festival Foundation.
  
• Divyang Ratna Award 2018 by Disable Welfare Trust of India.

2019

• Mumbai Heroes Award from Blossom Media Pvt Ltd at the Humanity First Conclave.
  
• Inspiring Indian Award from Indian Ex Defence Service Employees Chamber of Commerce & Industries (IESECCI).
  
• Award for Peace Mobilization from Poddar Foundation at the Insure your Mental Health Conference (Celebrating World Health Day).
  
• Inspirational Indian of the Year at the The Mumbai Achievers Awards 2019 by Mumbai Halchal.
  
• Bharat Shree Award 2019.
  
• Rotary Award from Rotary Club of Mumbai Khar.
  
• H F F Excellence Award from Humanity First Foundation.

2020

• ‘For the Sake of Honour’ Award from Rotary.
  
• Excellence in Human Welfare Award from Charity with a Twist, Nargis Dutt Foundation, ECOMO.

• Dr. Habil Khorakiwala bestowed Lifetime Achievement award by Integrated Health and Wellbeing Council in Dubai
• Wockhardt wins prestigious innovator award from Government of India.

Milestones

• 1967: Wockhardt founded by Dr. Habil Khorakiwala.
• 1972: Launch of PROXYVON - the first combination formulation in pain management.
• 1979: First in India to bring POVIDONE IODINE (BETADINE) to manage sepsis in collaboration with Mundi Pharma of Switzerland.
• 1979: First modern manufacturing plant commissioned at Chikalthana, Chhatrapati Sambhajinagar.
• 1995: First UK MCA and Australia TGA approval received.
• 1999: Incorporated as Wockhardt Ltd. and listed on the stock exchange.
• 2000: First recombinant product BIOVAC-B launched.
• 2003: Acquisition of CP Pharmaceuticals, UK.
• 2005: Launches India's 1st automatic insulin delivery device: WOSULIN PEN + Cartridges.
• 2005: Only pharmaceutical company in India to be recognised as 'Business Superbrand'.
• 2006: Acquisition of Pinewood Healthcare, Ireland.
• 2007: Acquisition of Morton Grove Pharmaceuticals, USA, & Negma, France.
• 2009: Wins Government of India Patent Award.
• 2013: Wins ‘Best Enterprise’ Award from Europe Business Assembly, Oxford, UK.
• 2017: Celebrates 50 Golden Years.
• 2018: Manufacturing and R&D unit in Dubai.
• 2020: 1st Indian Company to Achieve Approval for EMROK & EMROK O.
• 2020: QIDP for WCK 6777.
• 2020: Wockhardt partners with UK government for COVID-19 vaccine fill & finish.
• 2021: Wockhardt & Jemincare partner for novel respiratory antibiotic Nafithromycin.
• 2022: NIH, USA to conduct human Phase 1 trial of Wockhardt’s novel antibiotic WCK 6777.
• 2022: Wockhardt & Serum Life Sciences UK announce collaboration for manufacturing multiple vaccines in UK.
• 2024: CLSI awards high susceptibility breakpoints to Zaynich, Wockhardt's novel proprietary antibiotic.
• 2024: WCK 6777 granted Fast Track designation by USFDA, completes Phase I study conducted by NIH, US.
• 2025: Zaynich achieves highest-ever efficacy meeting superiority in a global, pivotal, registration enabling Phase III study in cUTI achieving 96.8% clinical cure rate.
• 2025: Zaynich – Global Phase III clinical study completed.
• 2025: Zaynich – NDA submission completed with the US FDA.
• 2026: Files Marketing Authorisation Application for WCK 5222 with European Medicines Agency.